DongKook Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	780,691	726,357	710,431	729,658	958,073	1,285,488
Market Cap Growth	11.95%	2.24%	-2.63%	-23.84%	-25.47%	64.14%
Enterprise Value	836,503	792,360	751,610	743,265	932,778	1,201,020
Last Close Price	17450.00	16520.00	15966.70	16218.07	21076.18	28053.09
PE Ratio	12.84	11.95	15.19	13.79	19.03	22.99
Forward PE	10.04	10.99	10.99	10.99	10.99	10.99
PS Ratio	0.87	0.89	0.97	1.10	1.61	2.30
PB Ratio	1.05	1.07	1.18	1.31	1.90	2.82
P/TBV Ratio	1.27	1.27	1.33	1.48	2.14	3.18
P/FCF Ratio	18.80	14.88	93.28	-	-	65.92
P/OCF Ratio	10.30	9.55	17.00	17.84	21.46	21.75
EV/Sales Ratio	0.93	0.98	1.03	1.12	1.57	2.15
EV/EBITDA Ratio	7.01	7.32	8.54	8.02	11.58	12.29
EV/EBIT Ratio	9.50	9.92	11.24	10.11	14.76	14.54
EV/FCF Ratio	20.14	16.24	98.69	-	-	61.59
Debt / Equity Ratio	0.10	0.12	0.13	0.12	0.19	0.15
Debt / EBITDA Ratio	0.61	0.74	0.87	0.72	1.22	0.70
Debt / FCF Ratio	1.76	1.65	10.07	-	-	3.51
Asset Turnover	0.91	0.91	0.91	0.87	0.84	0.93
Inventory Turnover	2.40	2.45	2.48	2.53	2.69	3.17
Quick Ratio	1.34	1.26	1.34	1.49	1.40	2.15
Current Ratio	2.08	2.02	2.06	2.22	1.91	2.75
Return on Equity (ROE)	9.51%	9.72%	8.42%	10.33%	11.03%	13.76%
Return on Assets (ROA)	5.72%	5.57%	5.20%	6.05%	5.59%	8.55%
Return on Invested Capital (ROIC)	9.66%	9.36%	9.75%	12.39%	12.30%	18.70%
Return on Capital Employed (ROCE)	11.60%	11.10%	10.50%	12.40%	11.90%	15.90%
Earnings Yield	7.75%	8.43%	6.64%	7.25%	5.25%	4.35%
FCF Yield	5.32%	6.72%	1.07%	-0.96%	-0.66%	1.52%
Dividend Yield	1.15%	1.21%	-	-	-	-
Payout Ratio	15.20%	13.58%	17.07%	15.22%	15.99%	12.79%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.02%	-0.01%	-	-
Total Shareholder Return	1.14%	1.20%	-0.02%	-0.01%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.